|
1
|
Ito H, Tsujimoto F, Nakajima Y, Igarashi
G, Okamura T, Sakurai M, Nobuoka S and Otsubo T: Sonographic
characterization of 271 hepatic hemangiomas with typical appearance
on CT imaging. J Med Ultrasonics. 39:61–68. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Li J, Huang L, Liu C, Yan J, Xu F, Wu M
and Yan Y: New recognition of the natural history and growth
pattern of hepatic hemangioma in adults. Hepatol Res. 46:727–733.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Okano H, Shiraki K, Inoue H, Ito T,
Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, et
al: Natural course of cavernous hepatic hemangioma. Oncol Rep.
8:411–414. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kim GE, Thung SN, Tsuji WM and Ferrell LD:
Hepatic cavernous hemangioma: Underrecognized associated histologic
features. Liver Int. 26:334–338. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gandolfi L, Leo P, Solmi L, Vitelli E,
Verros G and Colecchia A: Natural history of hepatic hemangiomas:
Clinical and ultrasound study. Gut. 32:677–680. 1991.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gibney RG, Hendin AP and Cooperberg PL:
Sonographically detected hepatic hemangiomas: Absence of change
over time. Am J Rentgenol. 149:953–957. 1967.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Erdogan D, Busch ORC, Delden OM, Bennink
RJ, Kate FJ, Gouma DJ and Guiik TM: Management of liver hemangiomas
according to size and symptoms. J Gastroenterol Hepatol.
22:1953–1958. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Duxburg MS and Garden OJ: Giant hemangioma
of the liver: Observation or resection? Dig Surg. 27:7–11.
2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Carlo ID, Koshy R, Mudares SA and Ardiri
A: Giant carvenous liver hemangiomas: Is it the time to change the
size categories? Hepatobiliary Pancreat Dis Int. 15:21–29.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Herman P, Coata ML, Machado MA, Pugliese
V, D'Albuquerque LA, Machado MC, Gama-Rodrigues JJ and Saad WA:
Management of hepatic hemangiomas: A 14-year experience. J
Gastrointest Surg. 9:853–859. 2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bozkaya H, Cinar C, Unalp OV, Parildar M
and Oran I: Unusual treatment of Kasabach-Merritt syndrome
secondary to hepatic hemangioma: Embolization with bleomycin. Wien
Klin Wochenschr. 127:488–490. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hall GW: Kasabach-Merritt syndrome:
Pathogenesis and management. Br J Hematol. 112:851–862.
2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rodriguez V, Lee A, Witman PM and Anderson
PA: Kasabach-merritt phenomenon: Case series and retrospective
review of the mayo clinic experience. J Pediatr Hematol Oncol.
31:522–526. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
O'Rafferty C, O'Regan GM, Irvine AD and
Smith OP: Recent advances in the pathobiology and management of
Kasabach-Merritt phenomenon. Br J Hematol. 171:38–51.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hoekstra LT, Bieze M, Erdogan D, Roelofs
JJ, Beuers UH and Gulik TM: Management of giant hemagiomas: An
update. Expert Rev Gastroenterol Hepatol. 7:263–268.
2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mewes T, Moldenhauer H, Pfeifer J and
Papenberg J: The Kasabach-Merritt syndrome: Severe bleeding
disorder caused by celiac arteriography-reversal by heparin
treatment. Am J Gastroenterl. 84:965–971. 1989.PubMed/NCBI
|
|
17
|
Wada H and Sakuragawa N: Are
fibrin-related markers useful for the diagnosis of thrombosis?
Semin Thromb Hemost. 34:33–38. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lee SY, Niikura T, Iwakura T, Sakai Y,
Kuroda R and Kurosaka M: Thrombin-antithrombin III complex tests: A
useful screening tool for postoperative venous thromembolism in
lower limb and pelvic fracture. J Orthop Surg. 25:1–6.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Deng Y, He L, Yang J and Wang J: Serum
D-dimer as an indicator of immediate mortality in patients with
in-hospital cardiac arrest. Thromb Res. 143:161–165.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tang L, Liu K, Wang J, Wang C, Zhao P and
Liu J: High preoperative plasma fibrinogen levels are associated
with distant metastases and impaired prognosis after curative
resection in patients with colorectal cancer. J Surg Oncol.
102:428–432. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang GY, Jiang N, Yi HM, Wang GS, Zhang
JW, Li H, Zhang J, Zhang Q, Yang Y and Chen GH: Pretransplant
elevated plasma fibrinogen level is a novel prognostic predictor
for hepatocellular carcinoma recurrence and patient survival
following liver transplantation. Ann Transplant. 21:125–130.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Suzuki H, Nimura Y, Kamiya J, Kondo S,
Nagino M, Kanai M and Miyachi M: Preoperative transcatheter
arterial embolization for giant carvenous hemangioma of the liver
with consumption coagulopathy. Am J Gastroenterol. 92:688–691.
1997.PubMed/NCBI
|
|
23
|
Blix S and Aas K: Giant hemangioma,
thrombocytopenia, fibrinogenopenia, and fibrinolytic activity. Acta
Med Scand. 169:63–70. 1961.
|
|
24
|
Wochner RD, Kulapongs P and Bachmann F:
125I-fibrinogen turnover and coagulation studies in a patient with
Kasabach-Merritt syndrome. J Lab Clin Med. 70(997)1967.
|
|
25
|
Hillman RS and Philips LL:
Clotting-fibrinolysis in a cavernous hemangioma. Am J Dis Child.
113:649–653. 1967.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Iwaki Y: Pathophysiology of portal
hypertension. Cli Liver Dis. 18:281–291. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
McConnell M and Iwakiri Y: Biology of
portal hypertension. Hepatol Int. 12 (Suppl 1):S11–S23.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mehta G, Gustot T, Mookerjee RP,
Garcia-Pagan JC, Fallon MB, Shah VH, Moreau R and Jalan R:
Inflammation and portal hypertension-The undiscovered country. J
Hepatol. 61:155–163. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Shirabe K, Bekki Y, Gantumur D, Araki K,
Ishii N, Kuno A, Narimatsu H and Mizokami M: Mac-2 binding protein
glycan isomer (M2BPGi) is a new serum biomarker for assessing liver
fibrosis: More than a biomarker of liver fibrosis. J Gastroenterol.
53:819–826. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Toshima T, Shirabe K, Ikegami T, Yoshizumi
T, Kuno A, Togayachi A, Gotoh M, Narimatsu H, Korenaga M, Mizokami
M, et al: A novel serum marker, glycosylated Wisteria floribunda
agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for
assessing liver fibrosis. J Gastroenterol. 50:76–84.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kobayashi T, Kawano M, Tomita Y, Tamano M,
Saigusa S, Horinaka M, Monma T, Koguma T, Yanagisawa N, Ohe T, et
al: Follow-up study of hepatic hemangiomas. Nippon Shokakibyo
Gakkai Zasshi. 92:41–46. 1995.PubMed/NCBI(In Japanese).
|
|
32
|
Miyaki D, Aikata H, Waki K, Murakami H,
Hashimoto Y, Nagaoki H, Katamura Y, Kataoka T, Takagi S, Hiramatsu
K, et al: Significant regression of a cavernous hepatic hemangioma
to a sclerosed hemangioma over 12 years: A case study. Nippon
Shokakibyo Gakkai Zasshi. 108:954–961. 2011.PubMed/NCBI(In Japanese).
|
|
33
|
Yeh WC, Yang PM, Huang GT, Sheu JC and
Chen DS: Long-term follow-up of hepatic hemangiomas by
ultrasonography: With emphasis on the growth rate of the tumor.
Hepatogastroenterology. 54:475–479. 2007.PubMed/NCBI
|
|
34
|
Nghiem HV, Bogost GA, Ryan JA, Lund P,
Freeny PC and Rice KM: Cavernous hemangiomas of liver: Enlargement
over time. Am J Rentgenol. 169:137–140. 1997.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bree RL, Schwab RE and Neiman HL: Solitary
echogenic spot in the liver: Is it diagnostic of a hemangioma? Am J
Rentgenol. 140:41–45. 1983.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tsumaki N, Waguri N, Yonayama O, Hama H,
Kawahisa J, Yokoo K, Aiba T, Furukawa K, Sugimura K, Igarashi K, et
al: A case of sclerosed hemangioma with a significant morphological
change over a period of 17 years. Kanzo. 49:268–274. 2008.
|
|
37
|
Ogawa K, Takeuchi K, Okuda C, Tamura T,
Koizumi Y, Koyama R, Imamura T, Inoue Y and Arase Y: Change in size
of hepatic hemangiomas during long-term observation: 80 lesions
with observation for over 10 years. Jpn J Med Ultrasonics.
41:749–756. 2014.
|
